A Pilot Study on Whey Protein Supplementation in Non Alcoholic Fatty Liver Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

11 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-04-30

Study Completion Date

2010-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An increase in dietary protein intake has been shown to blunt the increase in intrahepatic fat induced by high fat feeding in healthy individuals. The purpose of this study is to determine if a protein supplementation decreases intrahepatic fat in obese patients with non-alcoholic fatty liver disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins

NCT04564391

Type2 Diabetes NAFLD

RECRUITING NA

Dairy Protien Rich Diet for NAFLD Patients

NCT04841915

Non-Alcoholic Fatty Liver Disease Metabolic Syndrome Caseins +4 more

COMPLETED NA

Effects of Dietary Proteins on Hepatic Lipid Metabolism

NCT00558740

Metabolic Syndrome X

COMPLETED

Dose-response Effect of Whey Protein Consumed as Pre-meal on Postprandial Lipaemia in Subjects With Metabolic Syndrome

NCT02087124

Metabolic Syndrome

COMPLETED NA

Effect of 12-week Milk Fat Globule Membrane Supplementation on the Human Muscle Function of Healthy, Recreationally Active Adults

NCT06573749

Ageing Well Neuromuscular Function

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

12 obese patients will be be treated with a dietary whey protein supplementation over 4 weeks. Their intrahepatic fat content, glucose tolerance, and body weight will be evaluated before and after 4 weeks of supplementation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-alcoholic Fatty Liver Disease Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Group Type EXPERIMENTAL

ProWHEY 94 CFM, SponserR

Intervention Type DIETARY_SUPPLEMENT

3 times 20g per day

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ProWHEY 94 CFM, SponserR

3 times 20g per day

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI higher than 35 kg/m2
* age 18-50 years
* sex male or female
* ASAT/ALAT \> 1.8

Exclusion Criteria

* treatment with hypolemic or antidiabetic agents
* blood glucose \> 7 mmol/l
* alcohol intake \> 20g/day
* creatinin \> 120 umol/l)
* contra-indications to Magnetic resonnance imaging

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No